OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
YASS57

Yash Optics & Lens Ltd

Medical Equipment, Supplies & DistributionVerified

Yash Optics & Lens Ltd maintains a strong liquidity position with a current ratio of 8.5, indicating a robust ability to meet short-term obligations. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio of 0.16 suggests a conservative capital structure, with long-term debt accounting for 146.007 million INR against total equity of 903.671 million INR. The company's profitability is reflected in a return on equity (ROE) of 10.61% and a return on assets (ROA) of 8.56%, both of which are strong indicators of efficient capital utilization and asset management. These metrics align with the industry's preference for ROIC and ROA as key performance indicators. The operating margin, calculated as operating income of 113.8 million INR on revenue of 432.085 million INR, is 26.34%, which is a strong margin for the optical lens manufacturing industry. Geographically, the company's revenue concentration is not disclosed in the input data, but the product portfolio spans a wide range of brands and categories, indicating a diversified approach to market segments. The company's product offerings include single vision, bifocal, and progressive lenses, with brands such as Alioth Endurance, Maestro Infinite, and ISmart. The company's growth trajectory is supported by a revenue of 432.085 million INR, with a gross profit of 281.707 million INR. While the outlook for the current fiscal year is not explicitly provided, the company's strong operating cash flow of 56.769 million INR and a net income of 95.881 million INR suggest a stable financial position. The capital expenditure of -115.331 million INR indicates a significant investment in long-term assets, which could support future growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's free cash flow is negative at -7.416 million INR, which may limit its ability to fund operations without external financing. However, the dilution risk is low, and the company has not issued additional shares recently. The key flag of negative net cash after subtracting total debt suggests a need for careful monitoring of liquidity management. Recent events and filings are not explicitly detailed in the input data, but the company's financial snapshot indicates a stable and profitable operation with a focus on maintaining a strong equity position. The company's strategic emphasis on a diverse product portfolio and brand presence supports its market position in the optical lens industry.

30-day price · YASS+19.10 (+17.4%)
Low$106.00High$140.50Close$129.10As of17 May, 00:00 UTC
Profile
CompanyYash Optics & Lens Ltd
TickerYASS.NS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Yash Optics & Lens Ltd is engaged in the manufacturing, trading, distribution, and supplying of a comprehensive range of spectacle and optical lenses, including single vision, bifocal, and progressive lenses, with a product portfolio of approximately 37 branded products.

Classification. The company is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

Yash Optics & Lens Ltd maintains a strong liquidity position with a current ratio of 8.5, indicating a robust ability to meet short-term obligations. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio of 0.16 suggests a conservative capital structure, with long-term debt accounting for 146.007 million INR against total equity of 903.671 million INR. The company's profitability is reflected in a return on equity (ROE) of 10.61% and a return on assets (ROA) of 8.56%, both of which are strong indicators of efficient capital utilization and asset management. These metrics align with the industry's preference for ROIC and ROA as key performance indicators. The operating margin, calculated as operating income of 113.8 million INR on revenue of 432.085 million INR, is 26.34%, which is a strong margin for the optical lens manufacturing industry. Geographically, the company's revenue concentration is not disclosed in the input data, but the product portfolio spans a wide range of brands and categories, indicating a diversified approach to market segments. The company's product offerings include single vision, bifocal, and progressive lenses, with brands such as Alioth Endurance, Maestro Infinite, and ISmart. The company's growth trajectory is supported by a revenue of 432.085 million INR, with a gross profit of 281.707 million INR. While the outlook for the current fiscal year is not explicitly provided, the company's strong operating cash flow of 56.769 million INR and a net income of 95.881 million INR suggest a stable financial position. The capital expenditure of -115.331 million INR indicates a significant investment in long-term assets, which could support future growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's free cash flow is negative at -7.416 million INR, which may limit its ability to fund operations without external financing. However, the dilution risk is low, and the company has not issued additional shares recently. The key flag of negative net cash after subtracting total debt suggests a need for careful monitoring of liquidity management. Recent events and filings are not explicitly detailed in the input data, but the company's financial snapshot indicates a stable and profitable operation with a focus on maintaining a strong equity position. The company's strategic emphasis on a diverse product portfolio and brand presence supports its market position in the optical lens industry.
Key takeaways
  • Yash Optics & Lens Ltd maintains a strong liquidity position with a current ratio of 8.5, indicating a robust ability to meet short-term obligations.
  • The company's profitability is reflected in a return on equity (ROE) of 10.61% and a return on assets (ROA) of 8.56%, both of which are strong indicators of efficient capital utilization and asset management.
  • The company's product portfolio spans a wide range of brands and categories, indicating a diversified approach to market segments.
  • The company's growth trajectory is supported by a revenue of 432.085 million INR, with a gross profit of 281.707 million INR.
  • The risk assessment highlights a medium liquidity risk and a low dilution risk, with a key flag of negative net cash after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$432.1M
Gross profit$281.7M
Operating income$113.8M
Net income$95.9M
R&D
SG&A
D&A
SBC
Operating cash flow$56.8M
CapEx-$115.3M
Free cash flow-$7.4M
Total assets$1.12B
Total liabilities$216.1M
Total equity$903.7M
Cash & equivalents
Long-term debt$146.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$903.7M
Net cash-$146.0M
Current ratio8.5
Debt/Equity0.2
ROA8.6%
ROE10.6%
Cash conversion59.0%
CapEx/Revenue-26.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricYASSActivity
Op margin26.3%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin22.2%8.6% medp25 2.7% · p75 12.7%top quartile
Gross margin65.2%64.0% medp25 60.1% · p75 65.6%above median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-26.7%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity16.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 13:48 UTC#f2e97aae
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 14:38 UTCJob: 2096e5cb